S. Dmitrienko, A. Yu, R. Balshaw, R.J. Shapiro, P.A. Keown

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

An alcoholic patient with recurrent renal failure and proteinuria T. Kumagai, Y. Hori, G. Seki, Toshiro Fujita Kidney International Volume 70, Issue 8,

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Volume 83, Issue 3, Pages (March 2013)

Stem cells for kidney repair: useful tool for acute renal failure?

Continuous renal replacement therapy in the critically ill patient

Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real? S. Andrulli, S. Di Filippo, F. Locatelli

Volume 71, Issue 8, Pages (April 2007)

Cytomegalovirus Infection after Allogeneic Transplantation: Comparison of Cord Blood with Peripheral Blood and Marrow Graft Sources Christopher M. Walker,

End-stage renal failure from asymptomatic bilateral ureteric stones

Volume 70, Pages S21-S25 (December 2006)

Long-neglected stent in a transplanted kidney

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age B.O. Eriksen, O.C. Ingebretsen Kidney International

Anemia as a risk factor for chronic kidney disease

A new era in phosphate binder therapy: What are the options?

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

Acute myocardial infarction in patients with end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants1 Lyndsay S. Baines, John T. Joseph,

Volume 70, Issue 12, Pages (December 2006)

David Del Bello, Michael J. Ross, Shirish S. Huprikar

Blood pressure targets in hemodialysis patients

Volume 70, Issue 7, Pages (October 2006)

Fructose intake as a risk factor for kidney stone disease

Volume 62, Issue 1, Pages (July 2002)

The third World Kidney Day: Looking back and thinking forward

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

J.M. van den Akker, J.F.M. Wetzels, A.J. Hoitsma Kidney International

Microbiology and outcomes of peritonitis in North America

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 85, Issue 1, Pages 3-4 (January 2014)

Volume 73, Issue 7, Pages (April 2008)

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

What can be learned using microarrays?

Volume 71, Issue 4, Pages (February 2007)

Volume 71, Issue 12, Pages (June 2007)

Volume 66, Issue 3, Pages (September 2004)

A man with a hole in his penis

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Organ transplantation goes to the movies

Does equal care give equal outcomes?

The Iranian model of living renal transplantation

Volume 70, Issue 8, Pages (October 2006)

Volume 70, Issue 7, Pages (October 2006)

Volume 72, Issue 8, Pages (October 2007)

Volume 69, Issue 10, Pages (May 2006)

Treatment of the primary hyperoxalurias: A new chapter

Volume 70, Issue 7, Pages (October 2006)

Is complement a target for therapy in renal disease?

Volume 70, Issue 3, Pages (August 2006)

Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate S. Aime, C. Canavese, P. Stratta Kidney International

Volume 70, Issue 5, Pages (September 2006)

H.J. Chin, H. Ro, H.J. Lee, K.Y. Na, D.-W. Chae Kidney International

The international realities of live donor kidney transplantation

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 69, Issue 8, Pages (April 2006)

Tetany during bicarbonate loading test

Volume 57, Issue 2, Pages (October 2000)

Global trends in the rates of living kidney donation

Volume 70, Issue 6, Pages (September 2006)

Characteristics of sudden death in hemodialysis patients

P.A. McFarlane, A.M. Bayoumi, A. Pierratos, D.A. Redelmeier

Presentation transcript:

The use of consensus guidelines for management of cytomegalovirus infection in renal transplantation S. Dmitrienko, A. Yu, R. Balshaw, R.J. Shapiro, P.A. Keown Kidney International Volume 72, Issue 8, Pages 1014-1022 (October 2007) DOI: 10.1038/sj.ki.5002464 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Cumulative probability of CMV infection following renal transplantation. Kidney International 2007 72, 1014-1022DOI: (10.1038/sj.ki.5002464) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Distribution of patients according to use of antiviral prophylaxis or pre-emptive therapy, and occurrence of asymptomatic or symptomatic CMV infection. Kidney International 2007 72, 1014-1022DOI: (10.1038/sj.ki.5002464) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Estimated direct treatment costs for patient populations according to antiviral prophylaxis strategy: scenario 1, prophylaxis for D+/R− transplants only; scenario 2, prophylaxis for all transplants with CMV-positive donor; scenario 3, prophylaxis for all transplants with a CMV-positive donor or recipient. Kidney International 2007 72, 1014-1022DOI: (10.1038/sj.ki.5002464) Copyright © 2007 International Society of Nephrology Terms and Conditions